SVA [SINOVAC BIOTECH] 6-K: Sinovac Schedules 2010 Annual Meeting of Shareholders Beijing

[Sinovac Schedules 2010 Annual Meeting of Shareholders Beijing — June 18, 2010 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi] [June 1 , 20 10 Dear Shareholder: You are cordially invited to attend the 20 10 annual meeting of shareholders of Sinovac Biotech Ltd. to be held on July 15, 2010 , at 9 : 00 A .M. Beijing time, at No. 39 Shangdi Xi Road, Haidian District, Beijing 100085, People’s Republic of China, and at the corresponding time in] [SINOVAC BIOTECH LTD. ( Incorporated in Antigua and Barbuda with limited liability) ( NASDAQ Ticker: SVA) FORM OF PROXY FOR 20 10 ANNUAL SHAREHOLDERS MEETING (AND ANY ADJOURNMENT THEREOF) (Note 1) I/We, 10 (Note 2) Annual Shareholders Meeting 10 Annual Shareholders meeting of the Company to be held on July 1 5 , 20 10 at 9:00 A.M. Beijing time] [1 -32371 SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F x Form 40-F o o o SINOVAC BIOTECH LTD.]

By | 2016-03-24T02:59:48+00:00 June 21st, 2010|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

SVA [SINOVAC BIOTECH] CORRESP: 41st Floor, One Exchange Square 8 Connaught Place,

[41st Floor, One Exchange Square 8 Connaught Place, Central Hong Kong Tel: +852.2522.7886 Fax: +852.2522.7006 www.lw.com FIRM / AFFILIATE OFFICES Abu Dhabi Moscow Barcelona Munich Beijing New Jersey Brussels New York June 15, 2010 Chicago Orange County Doha Paris VIA EDGAR Dubai Riyadh Frankfurt Rome Jim B. Rosenberg, Senior Assistant Chief Hamburg San Diego Don Abbott, Senior Staff Accountant]

By | 2016-03-24T03:02:26+00:00 June 15th, 2010|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13G/A: (Original Filing)

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 60,226,056 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656%]

By | 2016-04-02T19:56:29+00:00 June 3rd, 2010|Categories: Chinese Stocks, SEC Original, WX|Tags: , , , , , |0 Comments
Read More

WX [WuXi PharmaTech (Cayman)] SC 13G/A: Item 1: Reporting Person – FMR LLC Item

[Item 1: Reporting Person - FMR LLC Item 4: Delaware Item 5: 60,226,056 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656% Item 12: HC Cusip #929352920 Item 1: Reporting Person - Edward C. Johnson 3d Item 5: 0 Item 6: 0 Item 7: 64,626,784 Item 8: 0 Item 9: 64,626,784 Item 11: 11.656%]

By | 2016-04-02T19:57:40+00:00 June 3rd, 2010|Categories: Chinese Stocks, Webplus ver, WX|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-1: CALCULATION OF REGISTRATION FEE Title of Each Class

[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to Be Registered Amount to Be Registered] [UNDERWRITING AGREEMENT between SKYSTAR BIO-PHARMACEUTICAL COMPANY and RODMAN & RENSHAW, LLC as Representative SKYSTAR BIO-PHARMACEUTICAL COMPANY UNDERWRITING AGREEMENT New York, New York ___________ __, 2010 Rodman & Renshaw, LLC th 1251 Avenue of the Americas, 20 New York, New York 10020 Ladies and Gentlemen: Company Representative Underwriters Underwriter 1. Purchase and Sale of Securities. 1.1 Firm Securities 1.1.1. Nature and] [Form of Representative’s Option Agreement THE REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE OPTION EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTION AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED] [RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, California 90024 Telephone (310) 208-1183 Facsimile (310) 208-1154 ___________________, 2010 SKYSTAR BIO-PHARMACEUTICAL COMPANY Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China Re: SKYSTAR BIO-PHARMACEUTICAL COMPANY Ladies and Gentlemen: In connection with this opinion, we have examined originals or copies of the registration statement,] [Consent of Independent Registered Public Accounting Firm To the Board of Directors Skystar Bio-Pharmaceutical Company We consent to the use of our report dated March 31, 2010, with respect to the consolidated financial statements of Skystar Bio-Pharmaceutical Company and Subsidiaries (the “Company”) as of December 31, 2009 and 2008 and for the related statements of income and other comprehensive income,]

By | 2016-03-01T06:06:43+00:00 June 1st, 2010|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Read More

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] S-1: (Original Filing)

[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to Be Registered Amount to Be Registered] [UNDERWRITING AGREEMENT between SKYSTAR BIO-PHARMACEUTICAL COMPANY and RODMAN & RENSHAW, LLC as Representative SKYSTAR BIO-PHARMACEUTICAL COMPANY UNDERWRITING AGREEMENT New York, New York ___________ __, 2010 Rodman & Renshaw, LLC th 1251 Avenue of the Americas, 20 New York, New York 10020 Ladies and Gentlemen: Company Representative Underwriters Underwriter 1. Purchase and Sale of Securities. 1.1 Firm Securities 1.1.1. Nature and] [Form of Representative’s Option Agreement THE REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE OPTION EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTION AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED] [RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, California 90024 Telephone (310) 208-1183 Facsimile (310) 208-1154 ___________________, 2010 SKYSTAR BIO-PHARMACEUTICAL COMPANY Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian Province, P.R. China Re: SKYSTAR BIO-PHARMACEUTICAL COMPANY Ladies and Gentlemen: In connection with this opinion, we have examined originals or copies of the registration statement,] [Consent of Independent Registered Public Accounting Firm To the Board of Directors Skystar Bio-Pharmaceutical Company We consent to the use of our report dated March 31, 2010, with respect to the consolidated financial statements of Skystar Bio-Pharmaceutical Company and Subsidiaries (the “Company”) as of December 31, 2009 and 2008 and for the related statements of income and other comprehensive income,]

By | 2016-03-01T06:05:47+00:00 June 1st, 2010|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments
Read More
Skip to toolbar